CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 24 enrolled
Drug / intervention
Investigational Contact Lens +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03330275
NCT03330275Phase 2Completed

Evaluating the Impact of JJVC Senofilcon A - Based Contact Lens With New UV-blocker on Day and Night Driving Performance

Johnson & Johnson Vision Care, Inc.·interventional·Posted Nov 6, 2017·Updated Aug 7, 2018

In Brief

A Phase 2 clinical trial evaluating Investigational Contact Lens, Commercial ACUVUE OASYS, and 1 other intervention for Visual Performance. Completed, enrolled 24 participants across 1 site.

Detailed Summary

This is a bilateral, non-dispensing, randomized, subject masked, four visits, 3-period by 3- treatment crossover study. The objective of this study is to evaluate the effect of JJVC senofilcon A - based contact lens with new UV-blocker on vision and driving performance in both daytime and nighttime lighting under real world driving conditions. This will be achieved through field-based driving studies on a closed-road driving circuit at night and during the day. Quantitative methods will be used to assess vision and driving performance under a range of challenging conditions and appropriate masking, order of testing, randomization and control conditions will be used.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia
Collaborators--

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedNov 6, 2017
Enrollment StartSep 27, 2017
Primary CompletionDec 11, 2017
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 8.7 years ago

Interventions

Investigational Contact Lensdevice

JJVC senofilcon A-based contact lens with new UV-blocker

Commercial ACUVUE OASYSdevice

senofilcon A

Commercial ACUVUE OASYS and Spectaclesdevice

Senofilcon A and Spectacles